Supernus Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Abbott USD 6.95B 419M 2025-06
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Eisai JPY 285.38B 19.82B 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
Novo Nordisk A/S 18.44B 5.78B 2025-06
Pacira USD 300.48M 16.87M 2025-06
Perrigo USD 454.2M 44.3M 2025-06
Pfizer USD 1.64B 208M 2025-06
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12


Supernus Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.